LRP1 and cancer: These compact segments, termed mini-chaperones, can attach to peptides and be internalized via APC receptors such as CD91 and scavenger receptor class A, positioning them as valuable adjuvants for cancer immunotherapy and vaccines by boosting CTL responses to pathogens [19].